Melio
About:
Melio provides a quick and comprehensive blood test that detects all prevalent infections.
Website: https://www.melio.tech
Top Investors: IndieBio, SOSV, LongeVC, Vye Ventures, Lexi Ventures
Description:
Melio provides a quick and comprehensive blood test that detects all prevalent infections. Their technology allows for prompt and targeted therapy while also combating antibiotic resistance. Melio is headquartered in Santa Clara, California.
Total Funding Amount:
$4M
Headquarters Location:
Santa Clara, California, United States
Founded Date:
2018-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-06-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai